Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Improving Hand Functional Use in Subjects with Multiple Sclerosis Using a Musical Keyboard: A Randomized Controlled Trial.
Review of MR elastography applications and recent developments.
Intramuscular interferon beta-1a therapy in patients with relapsing-remitting multiple sclerosis: a 15-year follow-up study.
Ocrelizumab in multiple sclerosis: risks and benefits.
Mesenchymal stem cells protect CNS neurons against glutamate excitotoxicity by inhibiting glutamate receptor expression and function.
A qualitative exploration of the impact of a 12-week group exercise class for those moderately affected with multiple sclerosis.
2012 Annual Meeting: Primary Immune Deficiency Disease North American Conference
Amiloride HCI Tablets, USP 5 mg
Meralgia paresthetica after subcutaneous injection of glatiramer acetate.
Daclizumab reverses intrathecal immune cell abnormalities in multiple sclerosis.
Natural History of Multiple Sclerosis Symptoms
Acute disseminated encephalomyelitis in children: a single institution experience of 28 patients.
Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.
Bridging the Brain Disease Knowledge Gap Through Computational Modeling and Systems Biology
Plasma exchange in severe attacks of neuromyelitis optica.
Energy Cost of Walking and Its Association With Gait Parameters, Daily Activity, and Fatigue in Persons With Mild Multiple Sclerosis.
Frequent but nonspecific venous narrowing in paediatric multiple sclerosis.
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.
Mapi Pharma granted United States patent covering glatiramer depot for multiple sclerosis
Neuroproteomics and microRNAs studies in multiple sclerosis: transforming research and clinical knowledge in biomarker research.
Biplanar MRI for the assessment of the spinal cord in multiple sclerosis.
Effect of High-Dose Intravenous Methyl-prednisolone Treatment on Intraocular Pressure in Multiple Sclerosis Patients with Relapse.
Tysabri prescribing information
Neuromyelitis optica.
Active Biotech announce that European Medicines Agency accepts start of scientific review of the marketing authorization application for laquinimod in relapsing-remitting multiple sclerosis

Pages